ZYLOX-TONBRDG.MED.TECH.H1

Research ZYLOX-TONBRDG.MED.TECH.H1 (818) on Bullrun: market cap EUR 644.85M, P/E 19.4, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 644.85M; P/E is 19.4; dividend yield is 1.4%.

About ZYLOX-TONBRDG.MED.TECH.H1

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices.

Frequently asked questions

What is ZYLOX-TONBRDG.MED.TECH.H1's market cap?

ZYLOX-TONBRDG.MED.TECH.H1's market capitalization is EUR 644.85M.

What is ZYLOX-TONBRDG.MED.TECH.H1's P/E ratio?

ZYLOX-TONBRDG.MED.TECH.H1's price-to-earnings (P/E) ratio is 19.4.

Does ZYLOX-TONBRDG.MED.TECH.H1 pay a dividend?

ZYLOX-TONBRDG.MED.TECH.H1 has a dividend yield of 1.4%.

What does ZYLOX-TONBRDG.MED.TECH.H1 do?

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally.